Neumora Therapeutics (NMRA) Times Interest Earned (2022 - 2026)

Neumora Therapeutics (NMRA) posted quarterly Times Interest Earned of -$28.51 for Q1 2026, up 0.73% quarter-over-quarter from -$28.72 in Q4 2025.

Neumora Therapeutics (NMRA) Times Interest Earned (2022 - 2026) Analysis & Trends

Neumora Therapeutics' Times Interest Earned history runs 5 years deep, the most recent figure standing at -$28.51 for Q1 2026.

In Q1 2026, Times Interest Earned changed N/A year-over-year to -$28.51; the TTM figure through Mar 2026 stood at -$57.35 (changed N/A YoY), while the FY2025 annual figure was -$0.73, up 26.71% from the prior year.
Times Interest Earned for Q1 2026 stood at -$28.51, up from -$28.72 in the prior quarter.
The five-year high for Times Interest Earned was -$0.22 in Q4 2022, with the low at -$57.7 in Q3 2025.
The 5-year median for Times Interest Earned is -$1.26 (2024), against an average of -$16.85.
The sharpest annual moves came in 2024 and 2025: Times Interest Earned sank 110.35% in 2024, then plunged 5392.29% in 2025.
Neumora Therapeutics' Times Interest Earned stood at -$0.22 in 2022, then plunged by 166.3% to -$0.58 in 2023, then slumped by 81.8% to -$1.05 in 2024, then slumped by 2634.05% to -$28.72 in 2025, then increased by 0.73% to -$28.51 in 2026.
Business Quant data shows NMRA's Times Interest Earned at -$28.51 in Q1 2026, -$28.72 in Q4 2025, and -$57.7 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Times Interest Earned (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	2.84
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	24.64
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-0.19
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	8.18
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-0.01
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	0.61
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	2.82
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-0.08
10	Neumora Therapeutics	296.45 Mn	296.45 Mn	-	-28.51

Download Data